Revumenib as maintenance for AML following allogeneic stem cell transplantation.

Oral Presentation | Jun 2, 2026

Author

Goulart H, et al.

Congress

American Society of Clinical Oncology Annual Meeting

Chicago, Illinois | May 29 – June 2, 2026